title: Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist.
authors.forename: R
authors.initials: R
authors.lastname: Voltz
authors.forename: M
authors.initials: M
authors.lastname: Hartmann
authors.forename: S
authors.initials: S
authors.lastname: Spuler
authors.forename: A
authors.initials: A
authors.lastname: Scheller
authors.forename: N
authors.initials: N
authors.lastname: Mai
authors.forename: R
authors.initials: R
authors.lastname: Hohlfeld
authors.forename: T
authors.initials: T
authors.lastname: Yousry
mesh_terms: D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D008137:Longitudinal Studies; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D010865:Pilot Projects; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins; D012795:Sialoglycoproteins / Q000097:blood / Q000627:therapeutic use*
chemical_list: C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D012795:Sialoglycoproteins